Non-alchoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease that commonly goes undetected and leads to serious consequences such as liver transplant. Explore your NASH clinical research participation options.
In the early stages of fatty liver disease, there are typically minimal or no symptoms. This allows fatty liver to progress to NASH.
Individuals at greatest risk of developing NASH are those who are obese, have high blood sugar, and high cholesterol.
NASH is the 2nd leading cause of liver transplants in the U.S.
Why wait to help impact the future of NASH care? Participants may receive: